Utilization of Fucoidan Based on Nanodelivery in Health Promotion Perspective, Molecular Mechanism, and Community Empowerment: A Scoping Review
Abstract
Introduction: Fucoidan is a sulfated polysaccharide derived from brown algae with proven anticancer, antioxidant, and immunomodulatory properties. However, its clinical utilization remains limited due to high molecular weight and low bioavailability. Recent advances in nanodelivery systems provide promising strategies to overcome these limitations and align with community-based health promotion initiatives.
Methods: This scoping review adopted the PEOS framework (Population, Exposure, Outcome, Study Design) and PRISMA flow to map current evidence on fucoidan’s molecular mechanisms, nanocarrier innovations, and community empowerment perspectives. Literature searches were conducted in PubMed, ScienceDirect, EBSCO, and Google Scholar from 2015–2023 using keywords “fucoidan,” “nanoparticle,” “nanocarrier,” “molecular mechanism,” and “health promotion.” Twenty-three eligible articles were critically appraised using Hawker’s Quality Assessment Tool.
Results: Fucoidan exhibits anticancer effects through upregulation of Bax, downregulation of Bcl-2, activation of caspases, and inhibition of angiogenesis via NF-?B, MAPK, and Nrf2 signaling pathways. Nanodelivery systems including chitosan fucoidan nanoparticles, PEGylated PLGA, hydrogels, and microneedle patches enhanced stability, absorption, and targeted efficacy. Preclinical studies demonstrated tumor inhibition, wound healing, and immunomodulatory benefits. From a public health perspective, fucoidan-based nanotechnology supports health promotion through increased scientific literacy, integration into Health Promoting Hospitals, and economic empowerment of coastal communities producing brown algae.
Conclusion:Fucoidan represents a multifunctional bioactive compound whose efficacy is strengthened by nanodelivery innovation. Integrating molecular insights with health promotion and community empowerment creates a sustainable model linking biotechnology, preventive health, and local economic development. This review emphasizes the importance of interdisciplinary collaboration in translating marine biopolymers into accessible, evidence-based complementary therapies.
References
Jin JO., The therapeutic potential of the anticancer activity of fucoidan: Current advances and hurdles. Mar Drugs. 2021;19(5):265. doi:10.3390/md19050265.
Li B, et al. Fucoidan: structure and bioactivity.Int J Biol Macromol.2017;105:1215-1224. doi:10.1016/j.ijbiomac.2017.01.123
Tan J, et al. Pharmacokinetics of fucoidan and low molecular weight fucoidan. Springer. 2023.
Chiang CS. Fucoidan-based nanoparticles with inherently therapeutic efficacy for cancer treatment. 2021.
Etman SM, et al. Undaria pinnatifida fucoidan nanoparticles loaded with quinacrine … 2020/2021.
Jabbour R, et al. Health literacy, communication, and patient understanding: A systematic review.Health Commun.2020;35(10):1232–1244. doi:10.1080/10410236.2019.1635088
Atashrazm F., et al. Fucoidan and cancer: a multifunctional molecule with anti-cancer properties.Mar Drugs.2015;13(4):2327–2346. doi:10.3390/md13042327.
Lin Y., The anti-cancer effects of fucoidan: a review of both in vivo and in vitro studies.Cancer Cell Int.2020;20:588. doi:10.1186/s12935-020-01233-8.
Turrini E., Ten years of research on fucoidan and cancer: progress and future perspectives.Mar Drugs.2023;21(2):117.
Venkatesan J., Fucoidan-based nanoparticles: preparations and biomedical applications.Int J Biol Macromol.2022;210:235–248.
Haggag YA., Fucoidan in pharmaceutical formulations: recent advances and future perspectives.Carbohydr Polym.2023;305:120563.
Zahariev N., Novel fucoidan pharmaceutical formulations and their applications.Pharmaceuticals.2023;15(3):627.
Liu M., Synthesis and characterization of chitosan-fucoidan nanoparticles for drug delivery.Int J Biol Macromol.2022;206:53–62.
Younas A., A chitosan/fucoidan nanoparticle-loaded pullulan microneedle patch for transdermal drug delivery.Carbohydr Polym.2023;301:120434.
Souza AO., Silver nanoparticles containing fucoidan: green synthesis, characterization, and biological activity.Int J Biol Macromol.2022;210:22–31.
Wang Y., Biological activities of fucoidan and the factors mediating biological activities.Mar Drugs.2019;17(3):183. doi:10.3390/md17030183.
Flórez-Fernández N., et al. Fucoidan from Fucus vesiculosus: evaluation of structural features and bioactivity.Int J Biol Macromol.2023;243:125847.
Dubashynskaya NV., Nano-sized fucoidan interpolyelectrolyte complexes: preparation and characterization.Polymers (Basel).2023;15(2):389.
Fitton JH., Therapies from fucoidan: an update.Mar Drugs.2015;13(9):5920-5946. doi:10.3390/md13095920.
Obluchinskaya ED., et al. In vitro anti-inflammatory activities of fucoidans from five brown algae.Mar Drugs.2022;20(3):161. doi:10.3390/md20030161.
Abdelkader DH., et al. Insight into fucoidan-based PEGylated PLGA nanoparticles for controlled drug delivery.Int J Pharm.2022;621:121783.
Ohmes J., et al. Injectable thermosensitive chitosan–collagen hydrogel incorporating fucoidan nanoparticles for cancer therapy.Int J Biol Macromol.2022;214:458-469.
Lee ZH., Lee MF., Chen JH., et al. Fucoidan with three functions extracted from Sargassum aquifolium integrated with rice-husk synthesis dual-imaging mesoporous silica nanoparticles.Int J Biol Macromol.2022;216:315-328.
Arwan A, Syam S, Zikra M, Firmansyah F, Sabri Syahrir M, Aji Satria M. Health Behavior Study in Natural Disaster Vulnerability in Palu City (Case Study of Tondo Huntap, Palu City). Journal of Public Health and Pharmacy. 2024;4(3):254-66.
Liu Y., Xu Y., Zhang X., et al. On-demand release of fucoidan from a multilayered nanofiber patch for killing oral squamous cancer cells and promoting epithelial regeneration.Biomater Sci.2022;10(15):4598-4608. doi:10.1039/d2bm00517g.
Hamami SMA., et al. Nano transdermal delivery potential of fucoidan from Sargassum sp. (brown algae) as a chemoprevention agent for breast cancer treatment.J Drug Deliv Sci Technol.2022;72:103439.
Diana. Competence of Public Health Center Health Extension Officers in the Tual City Health Service Work Area. Journal of Public Health and Pharmacy. 2023;3(2):29-35.
Kolomboy F, Adhyanti A, Nurmiaty, Arsyad G, Aminuddin A, Faisal TI, et al. Cross-Sectoral Collaboration in Stunting Prevention: Implementation in Donggala Regency, Central Sulawesi.Journal of Public Health and Pharmacy. 2025;5(1):191-9.
Hetrianto ND, Pratiwi Putri DU, Arisandi W. Effectiveness of Using E-Puskesmas Application in Public Health Centre in the Work Area at Public Health Office. An Idea Nursing Journal. 2024;3(02):27-32.
Copyright (c) 2025 Media Publikasi Promosi Kesehatan Indonesia (MPPKI)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with Media Publikasi Promosi Kesehatan Indonesia retain the copyright of their work. The journal applies a Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), which grants the following rights:
-
Copyright Retention: Authors retain the copyright of their work, maintaining full control over their intellectual property without restrictions.
-
Right of First Publication: Authors grant the journal the right of first publication of their work. This ensures that the work is initially published and credited in Media Publikasi Promosi Kesehatan Indonesia.
-
License to Share and Reuse: The work is licensed under CC BY-SA 4.0, allowing others to copy, distribute, remix, and build upon the work for any purpose, even commercially, as long as proper credit is given to the authors, and any new creations are licensed under the same terms.
